About Ospedale Senatore Antonio Perrino
Clinical Trials at Ospedale Senatore Antonio Perrino
During the past decade, Ospedale Senatore Antonio Perrino conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Senatore Antonio Perrino"
#1 collaborator was "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator and "Clinical Trials Promoting Group (APRIC/CTPG)" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 19 trials.
Clinical Trials Conditions at Ospedale Senatore Antonio Perrino
According to Clinical.Site data, the most researched conditions in "Ospedale Senatore Antonio Perrino" are
"Ovarian Cancer" (7 trials), "Non-small Cell Lung Cancer Metastatic" (2 trials), "Non-small Cell Lung Cancer Stage IIIB" (2 trials), "Advanced Non-Small Cell Lung Cancer" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Ospedale Senatore Antonio Perrino" in a lesser frequency.
Clinical Trials Intervention Types at Ospedale Senatore Antonio Perrino
Most popular intervention types in "Ospedale Senatore Antonio Perrino" are "Drug" (14 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (4 trials), "Gemcitabine" (4 trials), "Paclitaxel" (4 trials), "paclitaxel" (4 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Ospedale Senatore Antonio Perrino
The vast majority of trials in "Ospedale Senatore Antonio Perrino" are
10 trials for "Female" genders and 5 trials for "All" genders.
Clinical Trials Status at Ospedale Senatore Antonio Perrino
Currently, there are NaN active trials in "Ospedale Senatore Antonio Perrino".
undefined are not yet recruiting,
1 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Ospedale Senatore Antonio Perrino,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Ospedale Senatore Antonio Perrino, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".